Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.

Advanced Hepatocellular Carcinoma (HCC) Clinical Trials

2 recruiting trials for Advanced Hepatocellular Carcinoma (HCC). Eligibility criteria explained in plain English.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
2
Total Trials
2
Recruiting Now
0
Phase 3 Trials
2
Sponsors

Recruiting Trials

RECRUITINGPhase 1 / Phase 2NCT07500220

Dual-Target GPC3/B7-H3 CAR-NK Cells for Advanced HCC

open-label trial of an allogeneic dual-target CAR-NK product directed against GPC3 and B7-H3 for adults with advanced hepatocellular carcinoma. The design intentionally uses GPC3...

Sponsor: Beijing BiotechEnrolling: 301 location
RECRUITINGPhase 1NCT07493044

An Open-Label, Phase I Clinical Trial of Super CAR-T With GPC3-Positive Advanced Hepatocellular Carcinoma

This study was a phase I safety and tolerability clinical trial conducted in a single-center, open-label, 3+3 design with dose escalation.

Sponsor: Guangzhou FineImmune Biotechnology Co., LTD.Enrolling: 151 location